News for Healthier Living

Immune-Targeting Vaccine Shows Promise Intercepting Cancer in Patients with Lynch Syndrome

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome (LS), according to a study from researchers at The University of Texas MD Anderson Cancer Center.

January 16, 2026


January 17 2026

January 16 2026

January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026

January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026